Skip to main content

#162290

SBP-SUMO2 expressing H1299 cell line

Cat. #162290

SBP-SUMO2 expressing H1299 cell line

Cat. #: 162290

Organism: Human

Tissue: Lung

Disease: Cancer

Model: Transgenic

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Petr Muller

Institute: Masaryk Memorial Cancer Institute

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: SBP-SUMO2 expressing H1299 cell line
  • Parental cell: H1299
  • Clone: H1299-947
  • Organism: Human
  • Gender: Male
  • Tissue: Lung
  • Donor: 43 years old, white
  • Disease: Cancer
  • Morphology: Epithelial
  • Growth properties: Adherent
  • Model: Transgenic
  • Model description: Expression of small ubiquitin-related modifier 2 (SUMO2) with a streptavidin binding protein (SPB) tag
  • Crispr: No
  • Conditional: No
  • Description: H1299 cell line derivative expressing the small ubiquitin-related modifier 2 (SUMO2) with a streptavidin binding protein (SPB) tag
  • Application: Cell culture
  • Biosafety level: BSL-2

Target Details

  • Target: SUMO2
  • Target background: SUMO2 binds to proteins as part of the post-translational modification and is involved in a variety of cellular processes, such as nuclear transport, transcriptional regulation, apoptosis, and protein stability

Applications

  • Application: Cell culture

Handling

  • Format: Frozen
  • Atmosphere: humidified CO2 atmosphere
  • Storage conditions: Liquid Nitrogen
  • Cultured in antibiotics: Yes, penicillin/streptomycin

References

  • Unpublished

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.